08-Dec-2020

PhagoMed Biopharma GmbH came 2nd and won €20.000 in one of the toughest contests for young European biotech companies, namely the Health Catapult of the European Institute of Innovation and Technology (EIT). The company´s synthetic lysin platform with bacterial vaginosis as a first target ...

more

Research team intends to use proteomics to accelerate the development of new drugs

21-Oct-2020

The fight against bacterial infections, especially those caused by resistant pathogens, is in full swing with the search for new antibiotic agents. The aim is to identify substances that attack the pathogens in a truly novel way. The team at the Center for Systems-Based Antibiotic Research ...

more

New process improves lab-on-chip devices to isolate drug-resistant strains of bacterial infection, viruses

22-Apr-2020

Engineering researchers developed a next-generation miniature lab device that uses magnetic nano-beads to isolate minute bacterial particles that cause diseases. Using this new technology improves how clinicians isolate drug-resistant strains of bacterial infections and difficult-to-detect ...

more

25-Mar-2020

Graphite nanoplatelets integrated into plastic medical surfaces can prevent infections, killing 99.99 per cent of bacteria which try to attach - a cheap and viable potential solution to a problem which affects millions, costs huge amounts of time and money, and accelerates antibiotic resistance. ...

more

New agents to fight multidrug-resistant germs

07-Jan-2020

Resistance to antibiotics is on the rise worldwide. Fraunhofer scientists have joined forces with partners in the Phage4Cure project to explore alternatives to antibiotics. One objective is to vanquish multidrug-resistant pathogens with viruses called bacteriophages. Another is to see these ...

more

The aryl-hydrocarbon receptor detects when bacteria increase so much in number that they become a danger to the body

23-Dec-2019

Bacterial infection does not automatically lead to illness; many germs only become dangerous when they occur in large numbers. Researchers at the Max Planck Institute for Infection Biology in Berlin have discovered that the body has a receptor, which doesn’t recognize bacteria themselves, but ...

more

17-Oct-2018

A research group at Tohoku University has made a significant discovery with positive implications for the development of bacteria-fighting drugs. The aminoacyl-tRNA site (A-site) of the 16S RNA decoding region in the bacterial ribosome looks promising for a new era of antibiotic drug ...

more

09-Oct-2018

By severely curtailing the effects of antibiotics, the formation of organized communities of bacterial cells known as biofilms can be deadly during surgeries and in urinary tract infections. Yale researchers have just come a lot closer to understanding how these biofilms develop, and potentially ...

more

Study proves effectiveness of sequential antibiotic treatment against the pathogen Pseudomonas aeruginosa

14-Sep-2018

The World Health Organization (WHO) warns that seemingly harmless bacterial infections could develop into one of the leading causes of death in the next few years, particularly in the industrialised countries. This dramatic threat arose because, in many cases, the antibiotics that have been ...

more

11-Sep-2018

Supported by funding from the Austrian Science Fund FWF, a team from the Max F. Perutz Laboratories deciphered the mechanism of the TTP protein as a time-switch for the programmed cell death of white blood cells. A targeted death of these cells prevents an excessive immune reaction, but could ...

more